The Modulation by Chlormethiazole of the GABAA-receptor Complex in Rat Brain

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 1989 Sep 1

PMID 2553191

Citations 16

Authors

A J Cross

J M Stirling

T N Robinson

D M Bowen

P T Francis

A R Green

Affiliations

Soon will be listed here.

Abstract

1. The interactions of chlormethiazole with gamma-aminobutyric acid (GABA) synthesis and release, and with ligand binding to sites associated with the GABAA-receptor complex and the GABAB-receptor have been studied in the rat. The GABAA-receptor was studied using [3H]-muscimol, [3H]-flunitrazepam was used to label the benzodiazepine modulatory site, and [35S]-butyl-bicyclophosphorothionate ([35S]-TBPS) to label the chloride channel. 2. Chlormethiazole had no effect on GABA synthesis in the cortex, hippocampus and striatum or on GABA release from cortical slices in vitro. Chlormethiazole did not displace [3H]-baclofen binding to the GABAB-receptor. 3. Chlormethiazole (IC50 = 140 microM) and pentobarbitone (IC50 = 95 microM) both inhibited [35S]-TBPS binding by increasing the rate of [35S]-TBPS dissociation. In addition, chlormethiazole caused an apparent decrease in the affinity of [35S]-TBPS binding. 4. Chlormethiazole enhanced the binding of [3H]-muscimol but had no effect on [3H]-flunitrazepam binding. In contrast, the sedative barbiturate pentobarbitone enhanced both [3H]-muscimol and [3H]-flunitrazepam binding. 5. It is concluded that the sedative and anticonvulsant effects of chlormethiazole are probably mediated through an action at the GABAA-receptor. However, chlormethiazole does not interact with the GABAA-receptor complex in an identical manner to the sedative barbiturate pentobarbitone.

Citing Articles

Multidimensional chemobehavior analysis of flavonoids and neuroactive compounds in zebrafish.

Bugel S, Tanguay R Toxicol Appl Pharmacol. 2018; 344:23-34.

PMID: 29499247 PMC: 5912343. DOI: 10.1016/j.taap.2018.02.019.

Novel analogues of chlormethiazole are neuroprotective in four cellular models of neurodegeneration by a mechanism with variable dependence on GABA(A) receptor potentiation.

VandeVrede L, Tavassoli E, Luo J, Qin Z, Yue L, Pepperberg D Br J Pharmacol. 2013; 171(2):389-402.

PMID: 24116891 PMC: 3904259. DOI: 10.1111/bph.12454.

Activity of chlormethiazole at human recombinant GABA(A) and NMDA receptors.

Usala M, Thompson S, Whiting P, Wafford K Br J Pharmacol. 2003; 140(6):1045-50.

PMID: 14530209 PMC: 1574126. DOI: 10.1038/sj.bjp.0705540.

Pharmacokinetics and sedative effects in healthy subjects and subjects with impaired liver function after continuous infusion of clomethiazole.

Centerholt C, Ekblom M, Odergren T, Borga O, Popescu G, Molz K Eur J Clin Pharmacol. 2003; 59(2):117-22.

PMID: 12734608 DOI: 10.1007/s00228-003-0598-y.

Investigation of the effect of chlormethiazole on cerebral chemistry in neurosurgical patients: a combined study of microdialysis and a neuroprotective agent.

Hutchinson P, OConnell M, Coles J, Chatfield D, Coleman M, Al-Rawi P Br J Clin Pharmacol. 2002; 53(3):275-83.

PMID: 11874391 PMC: 1874304. DOI: 10.1046/j.0306-5251.2001.01552.x.

References

Hall H, Thor L . Evaluation of a semiautomatic filtration technique for receptor binding studies. Life Sci. 1979; 24(24):2293-9. DOI: 10.1016/0024-3205(79)90107-3. View

Williams M, RISLEY E . Characterization of the binding of [3H]muscimol, a potent gamma-aminobutyric acid agonist, to rat brain synaptosomal membranes using a filtration assay. J Neurochem. 1979; 32(3):713-8. DOI: 10.1111/j.1471-4159.1979.tb04553.x. View

Leeb-Lundberg F, Snowman A, Olsen R . Barbiturate receptor sites are coupled to benzodiazepine receptors. Proc Natl Acad Sci U S A. 1980; 77(12):7468-72. PMC: 350525. DOI: 10.1073/pnas.77.12.7468. View

Leeb-Lundberg F, Snowman A, Olsen R . Interaction of anticonvulsants with the barbiturate-benzodiazepine-GABA receptor complex. Eur J Pharmacol. 1981; 72(1):125-9. DOI: 10.1016/0014-2999(81)90309-5. View

Study R, Barker J . Diazepam and (--)-pentobarbital: fluctuation analysis reveals different mechanisms for potentiation of gamma-aminobutyric acid responses in cultured central neurons. Proc Natl Acad Sci U S A. 1981; 78(11):7180-4. PMC: 349220. DOI: 10.1073/pnas.78.11.7180. View

Bowdler J, Green A . Regional rat brain benzodiazepine receptor number and gamma-aminobutyric acid concentration following a convulsion. Br J Pharmacol. 1982; 76(2):291-8. PMC: 2071793. DOI: 10.1111/j.1476-5381.1982.tb09219.x. View

Whittle S, Turner A . Differential effects of sedative and anticonvulsant barbiturates on specific [3H]GABA binding to membrane preparations from rat brain cortex. Biochem Pharmacol. 1982; 31(18):2891-5. DOI: 10.1016/0006-2952(82)90260-x. View

Bowery N, Hill D, Hudson A . Characteristics of GABAB receptor binding sites on rat whole brain synaptic membranes. Br J Pharmacol. 1983; 78(1):191-206. PMC: 2044790. DOI: 10.1111/j.1476-5381.1983.tb09380.x. View

Squires R, Casida J, Richardson M, Saederup E . [35S]t-butylbicyclophosphorothionate binds with high affinity to brain-specific sites coupled to gamma-aminobutyric acid-A and ion recognition sites. Mol Pharmacol. 1983; 23(2):326-36. View

10.

Thyagarajan R, Ramanjaneyulu R, Ticku M . Enhancement of diazepam and gamma-aminobutyric acid binding by (+)etomidate and pentobarbital. J Neurochem. 1983; 41(2):578-85. DOI: 10.1111/j.1471-4159.1983.tb04778.x. View

11.

Harrison N, Simmonds M . Two distinct interactions of barbiturates and chlormethiazole with the GABAA receptor complex in rat cuneate nucleus in vitro. Br J Pharmacol. 1983; 80(2):387-94. PMC: 2045014. DOI: 10.1111/j.1476-5381.1983.tb10045.x. View

12.

Ticku M, Ramanjaneyulu R . Differential interactions of GABA agonists, depressant and convulsant drugs with [35S]-t-butylbicyclophosphorothionate binding sites in cortex and cerebellum. Pharmacol Biochem Behav. 1984; 21(1):151-8. DOI: 10.1016/0091-3057(84)90145-x. View

13.

Hedlund B, Ogren S . Chlormethiazole acts on chloride channels in cultured spinal cord neurons. Neurosci Lett. 1987; 78(2):217-21. DOI: 10.1016/0304-3940(87)90636-7. View

14.

Simmonds M, Turner J . Potentiators of responses to activation of gamma-aminobutyric acid (GABAA) receptors. Neuropharmacology. 1987; 26(7B):923-30. DOI: 10.1016/0028-3908(87)90071-2. View

15.

Green A, Metz A, Minchin M, Vincent N . Inhibition of the rate of GABA synthesis in regions of rat brain following a convulsion. Br J Pharmacol. 1987; 92(1):5-11. PMC: 1853628. DOI: 10.1111/j.1476-5381.1987.tb11288.x. View

16.

Lohse M, Boser S, Klotz K, Schwabe U . Affinities of barbiturates for the GABA-receptor complex and A1 adenosine receptors: a possible explanation of their excitatory effects. Naunyn Schmiedebergs Arch Pharmacol. 1987; 336(2):211-7. DOI: 10.1007/BF00165807. View

17.

Procter A, Palmer A, Francis P, Lowe S, Neary D, Murphy E . Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer's disease. J Neurochem. 1988; 50(3):790-802. DOI: 10.1111/j.1471-4159.1988.tb02983.x. View

18.

Schwartz R . The GABAA receptor-gated ion channel: biochemical and pharmacological studies of structure and function. Biochem Pharmacol. 1988; 37(18):3369-75. DOI: 10.1016/0006-2952(88)90684-3. View

19.

Barker J, McBurney R . Phenobarbitone modulation of postsynaptic GABA receptor function on cultured mammalian neurons. Proc R Soc Lond B Biol Sci. 1979; 206(1164):319-27. DOI: 10.1098/rspb.1979.0108. View